Abstract
Background/Objectives:
The purpose of this study was to investigate whether vitamin B6 supplementation had a beneficial effect on inflammatory and immune responses in patients with rheumatoid arthritis (RA).
Subjects/Methods:
This was a single-blind co-intervention study performed at the Division of Allergy, Immunology and Rheumatology of Chung Shan Medical University Hospital, Taiwan. Patients were diagnosed with RA according to the 1991 American College of Rheumatology criteria for RA. Patients were randomly allocated into two groups: control (5 mg/day folic acid only; n=15) or vitamin B6 (5 mg/day folic acid plus 100 mg/day vitamin B6; n=20) for 12 weeks. Plasma pyridoxal 5′-phosphate (PLP), serum folate, inflammatory parameters (that is, high-sensitivity C-reactive protein (hs-CRP), erythrocyte sedimentation rate (ESR), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α)) and immune parameters (that is, white blood cell, total lymphocyte, T-cell (CD3), B-cell (CD19), T-helper cell (CD4), T-suppressor (CD8)) were measured on day 1 (week 0) and after 12 weeks (week 12) of the intervention.
Results:
In the group receiving vitamin B6, plasma IL-6 and TNF-α levels significantly decreased at week 12. There were no significant changes with respect to immune responses in both groups except for the percentage of total lymphocytes in the vitamin B6 group when compared with week 0 and week 12. Plasma IL-6 level remained significantly inversely related to plasma PLP after adjusting for confounders (β=−0.01, P=0.01).
Conclusions:
A large dose of vitamin B6 supplementation (100 mg/day) suppressed pro-inflammatory cytokines (that is, IL-6 and TNF-α) in patients with RA.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bates CJ, Pentieva KD, Matthews N, Macdonald A (1999). A simple, sensitive and reproducible assay for pyridoxal 5′-phosphate and 4-pyridoxic acid in human plasma. Chin Chim Acta 280, 101–111.
Casciato DA, McAdam LP, Kopple JD, Bluestone R, Goldberg LS, Clements PJ et al. (1984). Immunologic abnormalities in hemodialysis patients: improvement after pyridoxine therapy. Nephron 38, 9–16.
Cheng CH, Huang YC, Chang SJ, Lee BJ, Lin KL (2006). Vitamin B6 supplementation improves immune responses in critically ill patients. Eur J Clin Nutr 60, 1207–1213.
Cheng CH, Lin PT, Liaw YP, Ho CC, Tsai TP, Chou MC et al. (2008). Plasma pyridoxal 5′-phosphate and high sensitivity C-reactive protein are independently associated with the increased risk of coronary artery disease. Nutrition 24, 239–244.
Chiang EP, Bagley PJ, Selhub J, Nadeau M, Roubenoff R (2003). Abnormal vitamin B6 status is associated with severity of symptoms in patients with rheumatoid arthritis. Am J Med 114, 283–287.
Chiang EP, Smith DE, Selhub J, Dallal G, Wang YC, Roubenoff R (2005a). Inflammation cause tissue-specific depletion of vitamin B6 . Arthritis Res Ther 7, R1254–R1262.
Chiang EP, Selhub J, Bagley PJ, Dallal G, Roubenoff R (2005b). Pyridoxine supplementation corrects vitamin B6 deficiency but does not improve inflammation in patients with rheumatoid arthritis. Arthritis Res Ther 7, R1404–R1411.
Choy EH, Panayi GS (2001). Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med 344, 907–916.
Department of Health (2003). Dietary Reference Intakes (DRIs), 6th ed., Taipei, Taiwan, ROC.
Dominici R, Luraschi P, Franzini C (2004). Measurement of C-reactive protein: two high sensitivity methods compared. J Clin Lab Anal 18, 280–284.
Folkers K, Morita M, McRee J (1993). The activities of coenzyme Q10 and vitamin B6 for immune responses. Biochem Biophys Res Commun 193, 88–92.
Fox DA (1997). The role of T cells in the immunopathogenesis of rheumatoid arthritis. Arthritis Rheum 40, 598–609.
Friso S, Girelli D, Martinelli N, Olivieri O, Lotto V, Bozzini C et al. (2004). Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. Am J Clin Nutr 79, 992–998.
Friso S, Jacques PF, Wilson PWF, Rosenberg IH, Selhub J (2001). Low circulating vitamin B6 is associated with elevation of the inflammation marker C-reactive protein independently of plasma homocysteine levels. Circulation 103, 2788–2791.
Gabriel SE, Crowson CS, Kremers HM, Doran MF, Turesson C, O’Fallon WM et al. (2003). Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum 48, 54–58.
Galloway P, McMillan DC, Sattar N (2000). Effect of the inflammatory response on trace element and vitamin status. Ann Clin Biochem 37, 289–297.
Gori AM, Sofi F, Corsi AM, Gazzini A, Sestini I, Lauretani F et al. (2006). Predictors of vitamin B6 and folate concentrations in older persons: the InCHIANTI study. Clin Chem 52, 1318–1324.
Gray A, McMillan DC, Wilson C, Williamson C, O’Reilly DS, Talwar D (2004). The relationship between plasma and red cell concentrations of vitamins thiamine diphosphate, flavin adenine dinucleotide and pyridoxal 5-phospahte following elective knee arthroplasty. Clin Nutr 23, 1080–1083.
Guerne PA, Zuraw BL, Vaughan JH, Carson DA, Lotz M (1989). Synovium as a source of interleukin 6 in vitro: contribution to local and systemic manifestations of arthritis. J Clin Invest 83, 585–592.
Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F (1992). The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 35, 498–502.
Huang YC, Chang HH, Huang SC, Cheng CH, LeeBJ, Cheng SY et al. (2005). Plasma pyridoxal 5′-phosphate is a significant indicator of immune responses in the mechanically ventilated critically ill. Nutrition 21, 779–785.
Huppert FA, Solomour FA, O’Connor S, Morgan K, Sussams P, Brayne C (1998). Aging and lymphocyte subpopulations: whole-blood analysis of immune markers in a large population sample of elderly individuals. Exp Gerontol 33, 593–600.
Hussein MR, Fathi NA, El-Din AM, Hassan HI, Abdullah F, Al-Hakeem E et al. (2008). Alterations of the CD4(+), CD8 (+) T cell subsets, interleukins-1beta, IL-10, IL-17, tumor necrosis factor-alpha and soluble intercellular adhesion molecule-1 in rheumatoid arthritis and osteoarthritis: preliminary observations. Pathol Oncol Res 14, 321–328.
Kelly PJ, Kistler JP, Shih VE, Mandell R, Atassi N, Barron M et al. (2004). Inflammation, homocysteine, and vitamin B6 status after ischemic stroke. Stroke 35, 12–15.
Kuryliszyn-Moskal A (1998). Cytokines and soluble CD4 and CD8 molecules in rheumatoid arthritis: relationship to systematic vasculitis and microvascular capillaroscopic abnormalities. Clin Rheumatol 17, 489–495.
Madhok R, Crilly A, Watson J, Capell HA (1993). Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity. Ann Rheum Dis 52, 232–234.
Mclnnes IB, Schett G (2007). Cytokines in the pathogenesis of rheumatoid arthritis. Nat Rev Immunol 7, 429–442.
Meydani SN, Hayek M, Coleman L (1992). Influence of vitamins E and B6 on immune response. Ann N Y Acad Sci 669, 125–139.
Meydani SN, Ribaya-Mercado JD, Russell RM, Sahyoun N, Morrow FD, Gershoff SN (1991). Vitamin B-6 deficiency impairs interleukin 2 production and lymphocyte proliferation in elderly adults. Am J Clin Nutr 53, 1275–1280.
Moreland LW, Heck Jr LW, Koopman WJ (1997). Biologic agents for treating rheumatoid arthritis. Arthritis Rheum 40, 397–409.
Quasim T, McMillan DC, Talwar D, Vasilaki A, St J O′Reilly D, Kinsella J (2005). The relationship between plasma and red cell B-vitamin concentrations in critically-ill patients. Clin Nur 24, 956–960.
Rall LC, Meydani SN (1993). Vitamin B6 and immune competence. Nutr Rev 51, 217–225.
Roubenoff R, Dellaripa P, Nadeau MR, Abad LW, Muldoon BA, Selhub J et al. (1997). Abnormal homocysteine metabolism in rheumatoid arthritis. Arthritis Rheum 40, 718–722.
Roubenoff R, Roubenoff RA, Selhub J, Nadeau MR, Cannon JG, Freeman LM et al. (1995). Abnormal vitamin B6 status in rheumatoid cachexia. Association with spontaneous tumor necrosis factor α production and markers of inflammation. Arthritis Rheum 38, 105–109.
Talbott MC, Miller LT, Kerkvliet NI (1987). Pyridoxine supplementation: effect on lymphocyte responses in elderly persons. Am J Clin Nutr 46, 659–664.
Talwar D, Quasim T, McMillan DC, Kinsella J, Williamson C, O’Reilly DS (2003). Pyridoxal phosphate decreases in plasma but not erythrocytes during systemic inflammatory response. Clin Chem 49, 515–518.
Ward MM (2001). Recent improvements in survival in patients with rheumatoid arthritis: better outcomes or different study designs? Arthritis Rheum 44, 1467–1469.
Whittle SL, Hughes RA (2004). Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review. Rheumatology 43, 267–271.
Woolf K, Manore MM (2008). Elevated plasma homocysteine and low vitamin B-6 status in nonsupplementing older women with rheumatoid arthritis. J Am Diet Assoc 108, 443–453.
Acknowledgements
This study was supported by the National Science Council, Taiwan, ROC (NSC-94-2320-B-040-031).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Guarantor: Y-C Huang. Contributors: S-CH was responsible for data coding, hematological measurements, sample analyses and statistical analyses. JC-CW was responsible for the screening and intervention of subjects and interpretation of the results. DJW was responsible for the screening and flow-mediated vasodilation 2D imaging measurement of the brachial artery. Y-CH was responsible for the development of intellectual content and study design, interpretation of the results and drafting of the paper.
Rights and permissions
About this article
Cite this article
Huang, SC., Wei, JC., Wu, D. et al. Vitamin B6 supplementation improves pro-inflammatory responses in patients with rheumatoid arthritis. Eur J Clin Nutr 64, 1007–1013 (2010). https://doi.org/10.1038/ejcn.2010.107
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2010.107
Keywords
This article is cited by
-
Factors influencing vitamin B6 status in domestic cats: age, disease, and body condition score
Scientific Reports (2024)
-
Vitamin B6 regulates IL-33 homeostasis to alleviate type 2 inflammation
Cellular & Molecular Immunology (2023)
-
Effect of vitamin B6 on pain, disease severity, and psychological profile of fibromyalgia patients; a randomized, double-blinded clinical trial
BMC Musculoskeletal Disorders (2022)
-
The Relationship Between Mucosal Microbiota, Colitis, and Systemic Inflammation in Chronic Granulomatous Disorder
Journal of Clinical Immunology (2022)
-
Electrochemical determination of vitamin B6 (pyridoxine) by reformed carbon paste electrode with iron oxide nanoparticles
Ionics (2022)